ESMO: Bristol Myers moves Opdualag into phase 3 trials in competitive first-line lung cancer field

ESMO: Bristol Myers moves Opdualag into phase 3 trials in competitive first-line lung cancer field aliu Wed, 09/11/2024 - 16:41